NASDAQ:JAGX

Jaguar Health Shares Spike After 816% Revenue Jump, But Trial Results Still Key
····

Jaguar Health Shares Spike After 816% Revenue Jump, But Trial Results Still Key

Jaguar Health shares rose 9.2% to $3.67 Wednesday after first-quarter revenue jumped to $20.3 million, mainly from a U.S. licensing deal for Mytesi and Canalevia-CA1. Trading volume surged to 593,152 shares. Net loss narrowed to $7.0 million from $10.5 million a year earlier. The company’s crofelemer rare-disease trial advanced with its first pediatric patient entering an extension phase.
May 21, 2026

Stock Market Today

  • Guzman Y Gomez Shares Plunge 37% but Show Strong Growth Prospects
    May 29, 2026, 9:18 PM EDT. Guzman Y Gomez Ltd (ASX: GYG), an Australian Mexican restaurant chain, has seen its shares fall over 37% in the past year and more than 55% since December 2024. Despite the volatility, the company has ambitious growth plans, aiming to expand its Australian restaurant count from 242 to 1,000 within 20 years. It reported 20% network sales growth and 6.6% comparable sales growth in Australia in Q3 FY26, with underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) expected to rise 29% year-on-year to about AUD 85 million. Asian operations, particularly in Japan and Singapore, are growing at 15% per year but remain a small portion of total sales. Rising profit margins could further boost future earnings, making GYG a notable opportunity outside the volatile tech sector.